- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
January 21, 2020
Although January is just another month and the 2020s are just another decade, big changes in the calendar give us pause. As another year unfolds, I marvel at how far biomedical research has come and where it will take us in the next year and beyond.
January 9, 2020
New research is helping to clarify scientists’ understanding of how post-heart-attack cardiac function sometimes improves after injections of cells. Hearts are healing, not actually regenerating tissue as many thought, the new research suggests.
December 20, 2019
The taller you are the more likely you are to develop atrial fibrillation, according to a new study relying on genetic data from more than a million people. Every inch in height over 5 feet 7 inches translates into about a 3 percent increase in AFib risk, according to the Penn Medicine study.
December 12, 2019
Two patients with serious conditions have shown remarkable results after receiving cutting-edge treatment using CRISPR, the revolutionary gene-editing tool, to alter blood-producing stem cells.
December 4, 2019
Using data from the records of more than 400,000 patients in the UK Biobank, researchers from the University of Glasgow say they’ve been able to determine which of three kidney function tests is the most effective at predicting cardiovascular risk, which is associated with chronic kidney disease.
November 14, 2019
Stem cell transplants continue to yield positive results in patients with multiple sclerosis and other autoimmune diseases, with the latest milestone emerging from Northwestern Medicine and Mayo Clinic.
October 24, 2019
Unfortunately, an established test for ovarian cancer, the CA125 test, is limited in its power and not recommended for general screening. Researchers in Ireland have come up with a potential improvement, a blood test that may be able to detect ovarian cancer one to two years earlier than current approaches.
October 17, 2019
One dose of one treatment to defeat multiple types of cancers? That’s the intriguing, if far-off, possibility suggested by a new development by UCLA scientists working with mice. The scientists focused on boosting production of “killer” immune cells that, though powerful, aren’t naturally prevalent enough in humans to make much of a difference for cancer patients.
October 10, 2019
Veteran health care informatics expert Benjamin Bielak recently joined iSpecimen as its first Chief Information Officer. He is the subject of our latest Q&A… The iSpecimen Marketplace is often compared to eBay or Amazon for clarity, but it’s certainly more complicated than that. What are the biggest technology challenges of an online marketplace not for […]